quinolinic acid has been researched along with pyruvic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabbay, RA | 1 |
| Brand, MD; Harper, ME; Korzeniewski, B | 1 |
| Brown, GC; Oh, MH; Soboll, S | 1 |
| Hodgkins, PS; Schwarcz, R | 1 |
| Fujitani, S; Ishizaki-Koizumi, S; Nishiguchi, S; Sonaka, I | 1 |
| Kim, SU; McLarnon, JG; Ryu, JK | 2 |
| Di Stasi, AM; Domenici, MR; Mallozzi, C; Metere, A; Minetti, M; Pèzzola, A; Popoli, P | 1 |
| Choi, HB; McLarnon, JG; Ryu, JK | 1 |
| Meijer, AJ; Williamson, JR | 1 |
| Neale, SA; Salt, TE; Sathyasaikumar, KV; Schwarcz, R; Tararina, M; Weisz, F; Wu, HQ | 1 |
11 other study(ies) available for quinolinic acid and pyruvic acid
| Article | Year |
|---|---|
Quinolinate inhibition of gluconeogenesis is dependent on cytosolic oxalacetate concentration. An explanation for the differential inhibition of lactate and pyruvate gluconeogenesis.
Topics: Animals; Asparagine; Calcium; Cytosol; Gluconeogenesis; Lactates; Lactic Acid; Liver; Male; Oleic Acid; Oleic Acids; Oxaloacetates; Phosphoenolpyruvate Carboxykinase (GTP); Pyridines; Pyruvates; Pyruvic Acid; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains | 1985 |
Proportional activation coefficients during stimulation of oxidative phosphorylation by lactate and pyruvate or by vasopressin.
Topics: Animals; Binding Sites; Fatty Acids; Lactates; Lactic Acid; Male; Membrane Potentials; Mitochondria, Liver; Mitochondria, Muscle; Oxidative Phosphorylation; Pyruvates; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Wistar; Vasopressins | 1995 |
Control of oxidative phosphorylation, gluconeogenesis, ureagenesis and ATP turnover in isolated perfused rat liver analyzed by top-down metabolic control analysis.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adenosine Triphosphate; Ammonia; Amobarbital; Animals; Gluconeogenesis; Glucose; Hydroxybutyrates; Lactic Acid; Liver; Oxidative Phosphorylation; Oxygen Consumption; Perfusion; Pyruvic Acid; Quinolinic Acid; Rats; Urea; Valine | 1998 |
Metabolic control of kynurenic acid formation in the rat brain.
Topics: Animals; Brain; Corpus Striatum; Electrophysiology; Energy Metabolism; Formazans; Kynurenic Acid; Kynurenine; Male; Potassium; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Sodium; Substrate Specificity; Tetrazolium Salts; Veratridine | 1998 |
Mechanisms of the protective effect of L-alanine to D-galactosamine-induced hepatocellular injury: comparative studies of L-alanine and pyruvate.
Topics: Alanine; Albumins; Aminoisobutyric Acids; Aminooxyacetic Acid; Animals; Cells, Cultured; Galactosamine; Hepatocytes; L-Lactate Dehydrogenase; Liver Failure; Male; Oligomycins; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley | 2002 |
Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Huntington Disease; Interneurons; Male; Neurons; Neuroprotective Agents; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome | 2003 |
Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Topics: Animals; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Guanidines; Huntington Disease; Lactic Acid; Male; Neostriatum; Neuroglia; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Tyrosine | 2004 |
Quinolinic acid modulates the activity of src family kinases in rat striatum: in vivo and in vitro studies.
Topics: Animals; Corpus Striatum; CSK Tyrosine-Protein Kinase; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Excitatory Amino Acid Antagonists; Free Radicals; Huntington Disease; In Vitro Techniques; Male; Neurotoxins; Nitric Oxide Synthase; Oxidative Stress; Presynaptic Terminals; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; src-Family Kinases; Synaptosomes; Time Factors | 2006 |
Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Drug Synergism; Huntington Disease; Immunohistochemistry; Inflammation; Male; Minocycline; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase Type II; Oxidative Stress; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2006 |
Transfer of reducing equivalents across the mitochondrial membrane. I. Hydrogen transfer mechanisms involved in the reduction of pyruvate to lactate in isolated liver cells.
Topics: Amobarbital; Animals; Biological Transport; Gluconeogenesis; Hepatocytes; Hydrogen; Hypnotics and Sedatives; Lactic Acid; Male; Mitochondrial Membranes; Oleic Acid; Oxidation-Reduction; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley | 1974 |
Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects.
Topics: Aged; Animals; Brain; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fluoroquinolones; Glucose; Glutamine; Humans; In Vitro Techniques; Kynurenine; Male; Mice; Middle Aged; Piperazines; Postmortem Changes; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Tacrolimus; Temperature; Tissue Distribution; Transaminases; Veratridine; Xanthurenates | 2017 |